Lipid Profiles, Inflammatory Markers, and Insulin Therapy in Youth with Type 2 Diabetes

Journal of Pediatrics

Volumn 196, Issue , 2018, Pages 208-216.e2

  Levitt Katz, Lorraine E ^a   Bacha, Fida ^b   Gidding, Samuel S ^c   Weinstock, Ruth S ^d   El ghormli, Laure ^e   Libman, Ingrid ^f   Nadeau, Kristen J ^g   Porter, Kristin ^f   Marcovina, Santica ^h   McKay, S ^b   Haymond, M ^b   Anderson, B ^b   Bush, C ^b   Gunn, S ^b   Holden, H ^b   Jones, S M ^b   Jeha, G ^b   McGirk, S ^b   Thamotharan, S ^b   Cuttler, L ⁱ   Abrams, E ⁱ   Casey, T ⁱ   Dahms, W ⁱ   Ievers Landis, C ⁱ   Kaminski, B ⁱ   Koontz, M ⁱ   MacLeish, S ⁱ   McGuigan, P ⁱ   Narasimhan, S ⁱ   Geffner, M ^j   Barraza, V ^j   Chang, N ^j   Conrad, B ^j   Dreimane, D ^j   Estrada, S ^j   Fisher, L ^j   Fleury Milfort, E ^j   Hernandez, S ^j   Hollen, B ^j   Kaufman, F ^j   Law, E ^j   Mansilla, V ^j   Miller, D ^j   Munoz C ^j   Ortiz, R ^j   Ward, A ^j   Wexler, K ^j   Xu, Y K ^j   Yasuda, P ^j   Berkowitz, R ^k   Boyd, S ^k   Johnson, B ^k   Kaplan, J ^k   Keating, C ^k   Lassiter, C ^k   Lipman, T ^k   McGinley, G ^k   McKnight, H ^k   Schwartzman, B ^k   Willi, S ^k   Arslanian, S ^f   Foster, S ^f   Galvin, B ^f   Hannon, T ^f   Kriska, A ^f   Marcus, M ^f   Songer, T ^f   Venditti, E ^f   Goland, R ^l   Gallagher, D ^l   Kringas, P ^l   Leibel, N ^l   Ng, D ^l   Ovalles, M ^l   Seidman, D ^l   Laffel, L ^m   Goebel Fabbri, A ^m   Hall, M ^m   Higgins, L ^m   Keady, J ^m   Malloy, M ^m   Milaszewski, K ^m   Rasbach, L ^m   Nathan, D M ⁿ   Angelescu, A ⁿ   Bissett, L ⁿ   Ciccarelli, C ⁿ   Delahanty, L ⁿ   Goldman, V ⁿ   Hardy, O ⁿ   Larkin, M ⁿ   Levitsky, L ⁿ   McEachern, R ⁿ   Norman, D ⁿ   Nwosu, D ⁿ   Park Bennett, S ⁿ   Richards, D ⁿ   Sherry, N ⁿ   Steiner, B ⁿ   Tollefsen, S ^o   Carnes, S ^o   Dempsher, D ^o   Flomo, D ^o,t   Whelan, T ^o   Wolff, B ^o   Bowerman, D ^p   Bristol, S ^p   Bulger, J ^p   Hartsig, J ^p   Izquierdo, R ^p   Kearns, J ^p   Saletsky, R ^p   Trief, P ^p   Zeitler, P ^q   Abramson, N ^q   Bradhurst, A ^q   Celona Jacobs, N ^q   Higgins, J ^q   Kelsey, M ^q   Klingensmith, G ^q   Witten, T ^q   Copeland, K ^r   Boss, E ^r   Brown, R ^r   Chadwick, J ^r   Chalmers, L ^r   Chernausek, S ^r   Hebensperger, A ^r   Macha, C ^r   Newgent, R ^r   Nordyke, A ^r   Olson, D ^r   Poulsen, T ^r   Pratt, L ^r   Preske, J ^r   Schanuel, J ^r   Sternlof, S ^r   Lynch, J ^s   Amodei, N ^s   Barajas, R ^s   Cody, C ^s   Hale, D ^s   Hernandez, J ^s   Ibarra, C ^s   Morales, E ^s   Rivera, S ^s   Rupert, G ^s   Wauters, A ^s   White, N ^t   Arbelaez A ^t   Jones, J ^t   Jones, T ^t   Sadler, M ^t   Tanner, M ^t   Timpson, A ^t   Welch, R ^t   Caprio, S ^u   Grey, M ^u   Guandalini, C ^u   Lavietes, S ^u   Rose, P ^u   Syme, A ^u   Tamborlane, W ^u   Hirst, K ^e   Edelstein, S ^e   Feit, P ^e   Grover, N ^e   Long, C ^e   Pyle, L ^e   Linder, B ^v   Harting, J ^h   Shepherd, J ^w   Fan, B ^w   Marquez, L ^w   Sherman, M ^w   Wang, J ^w   Nichols, M ^x   Mayer Davis, E ^x   Liu, Y ^x   Lima, J ^y   Puccella, J ^y   Ricketts, E ^y   Danis, R ^z   Domalpally, A ^z   Goulding, A ^z   Neill, S ^z   Vargo, P ^z   Wilfley, D ^h   Aldrich Rasche, D ^h   Franklin, K ^h   Massmann, C ^h   O'Brien, D ^h   Patterson, J ^h   Tibbs, T ^h   Van Buren, D ^h   Palmert, M ^aa   Ratner, R ^ab   Dremaine, D ^ac   Silverstein, J ^ad   more..

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^d State University of New York Upstate Medical University: College of Medicine   (United States)

^e GEORGE WASHINGTON UNIVERSITY   (United States)

^f CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^g UNIVERSITY OF COLORADO   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ CASE WESTERN RESERVE UNIVERSITY   (United States)

^j CHILDREN S HOSPITAL LOS ANGELES   (United States)

^k CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^l Department of Medicine   (United States)

^m JOSLIN DIABETES CENTER   (United States)

ⁿ MASSACHUSETTS GENERAL HOSPITAL   (United States)

^o SAINT LOUIS UNIVERSITY   (United States)

^p SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^q UNIVERSITY OF COLORADO   (United States)

^r UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^s UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^t WASHINGTON UNIVERSITY   (United States)

^u YALE UNIVERSITY   (United States)

^v NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^w UNIVERSITY OF CALIFORNIA   (United States)

^x UNIVERSITY OF SOUTH CAROLINA   (United States)

^y JOHNS HOPKINS UNIVERSITY   (United States)

^z UNIVERSITY OF WISCONSIN   (United States)

^aa HOSPITAL FOR SICK CHILDREN   (Canada)

^ab MEDSTAR RESEARCH INSTITUTE   (United States)

^ac TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^ad UNIVERSITY OF FLORIDA   (United States)

more..

Author keywords

adolescent; inflammatory markers; insulin; lipids; type 2 diabetes mellitus

Indexed keywords

APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; FATTY ACID; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHRONIC INFLAMMATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DYSLIPIDEMIA; FATTY ACID BLOOD LEVEL; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; ANALYSIS; BLOOD; CHILD; CLINICAL TRIAL; DISEASE EXACERBATION; GLUCOSE BLOOD LEVEL; INFLAMMATION; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; BLOOD GLUCOSE; CHILD; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; DYSLIPIDEMIAS; FEMALE; GLYCATED HEMOGLOBIN A; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION; INSULIN; LIPIDS; MALE;

EID: 85041917429     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2017.12.052     Document Type: Article

References (35)

1. Capewell, S., Buchan, I., Why have sustained increases in obesity and type 2 diabetes not offset declines in cardiovascular mortality over recent decades in Western countries?. Nutr Metab Cardiovasc Dis 22 (2012), 307–311.
2. Wang, Y.C., McPherson, K., Marsh, T., Gortmaker, S.L., Brown, M., Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 378 (2011), 815–825.
3. Maahs, D.M., Daniels, S.R., de Ferranti, S.D., Dichek, H.L., Flynn, J., Goldstein, B.I., et al. Cardiovascular disease risk factors in youth with diabetes mellitus: a scientific statement from the American Heart Association. on behalf of the; American Heart Association Atherosclerosis, Hypertension and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council for High Blood Pressure Research, and Council on Lifestyle and Cardiometabolic Health Circulation 130 (2014), 1532–1558.
4. TODAY Study Group. Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes. Pediatr Diabetes 8 (2007), 74–87.
5. TODAY Study Group. Design of a family-based lifestyle intervention for youth with type 2 diabetes: the TODAY study. Int J Obes (Lond) 34 (2010), 217–226.
6. Flegal, K.M., Wei, R., Ogden, C.L., Freedman, D.S., Johnson, C.L., Curtin, L.R., Characterizing extreme values of body mass index-for-age by using the 2000 centers for disease control and prevention growth charts. Am J Clin Nutr 90 (2009), 1314–1320.
7. Littell, R.C., Milliken, G.A., Stroup, W.W., Wolfinger, R.D., Schabenberger, O., SAS for mixed models. 2nd ed, 2006, SAS Institute Inc., Cary (NC).
8. Naumova, E.N., Must, A., Laird, N.M., Tutorial in biostatistics: evaluating the impact of ‘critical periods’ in longitudinal studies of growth using piecewise mixed effects models. Int J Epidemiol 30 (2001), 1332–1341.
9. TODAY Study Group. Lipid and inflammatory cardiovascular risk worsens over 3years in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care 36 (2013), 1758–1764.
10. TODAY Study Group. Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and beta-cell function in TODAY. Diabetes Care 36 (2013), 1749–1757.
11. Shah, A.S., Urbina, E.M., Khoury, P.R., Kimball, T.R., Dolan, L.M., Lipids and lipoprotein ratios: contribution to carotid intima media thickness in adolescents and young adults with type 2 diabetes mellitus. J Clin Lipidol 7 (2013), 441–445.
12. Urbina, E.M., Kimball, T.R., Khoury, P.R., Daniels, S.R., Dolan, L.M., Increased arterial stiffness is found in adolescents with obesity or obesity-related type 2 diabetes mellitus. J Hypertens 28 (2010), 1692–1698.
13. Shah, A.S., Dolan, L.M., Kimball, T.R., Gao, Z., Khoury, P.R., Daniels, S.R., et al. Influence of duration of diabetes, glycemic control, and traditional cardiovascular risk factors on early atherosclerotic vascular changes in adolescents and young adults with type 2 diabetes mellitus. J Clin Endocrinol Metab 94 (2009), 3740–3745.
14. Magnussen, C.G., Venn, A., Thomson, R., Juonala, M., Srinivasan, S.R., Viikari, J.S., et al. The association of pediatric low- and high-density lipoprotein cholesterol dyslipidemia classifications and change in dyslipidemia status with carotid intima-media thickness in adulthood evidence from the cardiovascular risk in Young Finns study, the Bogalusa Heart study, and the CDAH (Childhood Determinants of Adult Health) study. J Am Coll Cardiol 53 (2009), 860–869.
15. Bonora, E., Kiechl, S., Oberhollenzer, F., Egger, G., Bonadonna, R.C., Muggeo, M., et al. Impaired glucose tolerance, type II diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study. Diabetologia 43 (2000), 156–164.
16. Hayashi, Y., Okumura, K., Matsui, H., Imamura, A., Miura, M., Takahashi, R., et al. Impact of low-density lipoprotein particle size on carotid intima-media thickness in patients with type 2 diabetes mellitus. Metabolism 56 (2007), 608–613.
17. Ridker, P.M., Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107 (2003), 363–369.
18. Choi, S.H., Ginsberg, H.N., Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance. Trends Endocrinol Metab 22 (2011), 353–363.
19. Cusi, K., Cunningham, G.R., Comstock, J.P., Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM. Diabetes Care 18 (1995), 843–851.
20. Noh, Y.H., Lee, S.M., Kim, E.J., Kim, D.Y., Lee, H., Lee, J.H., et al. Improvement of cardiovascular risk factors in patients with type 2 diabetes after long-term continuous subcutaneous insulin infusion. Diabetes Metab Res Rev 24 (2008), 384–391.
21. Rivellese, A.A., Patti, L., Romano, G., Innelli, F., Di Marino, L., Annuzzi, G., et al. Effect of insulin and sulfonylurea therapy, at the same level of blood glucose control, on low density lipoprotein subfractions in type 2 diabetic patients. J Clin Endocrinol Metab 85 (2000), 4188–4192.
22. Aslan, I., Kucuksayan, E., Aslan, M., Effect of insulin analog initiation therapy on LDL/HDL subfraction profile and HDL associated enzymes in type 2 diabetic patients. Lipids Health Dis, 12, 2013, 54.
23. Emanuele, N., Azad, N., Abraira, C., Henderson, W., Colwell, J., Levin, S., et al. Effect of intensive glycemic control on fibrinogen, lipids, and lipoproteins: Veterans Affairs Cooperative Study in Type II Diabetes Mellitus. Arch Intern Med 158 (1998), 2485–2490.
24. Lamharzi, N., Renard, C.B., Kramer, F., Pennathur, S., Heinecke, J.W., Chait, A., et al. Hyperlipidemia in concert with hyperglycemia stimulates the proliferation of macrophages in atherosclerotic lesions: potential role of glucose-oxidized LDL. Diabetes 53 (2004), 3217–3225.
25. The DCCT Research Group. Effect of intensive diabetes management on macro vascular events and risk factors in the Diabetes Control and Complications Trial. Am J Cardiol 75 (1995), 894–903.
26. Yki-Järvinen, H., Kauppinen-Mäkelin, R., Tiikkainen, M., Vähätalo, M., Virtamo, H., Nikkilä K., et al. Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study. Diabetologia 49 (2006), 442–451.
27. Holman, R.R., Paul, S.K., Bethel, M.A., Matthews, D.R., Neil, H.A., 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359 (2008), 1577–1589.
28. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein, H.C., Miller, M.E., Byington, R.P., Goff, D.C. Jr, Bigger, J.T., et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358 (2008), 2545–2559.
29. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358 (2008), 2560–2572.
30. Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P.D., et al. N Engl J Med 360 (2009), 129–139.
31. ORIGIN Trial Investigators, Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med 367 (2012), 319–328.
32. Zhang, H.H., Huang, J., Düvel, K., Boback, B., Wu, S., Squillace, R.M., et al. Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway. PLoS ONE, 4, 2009, e6189.
33. Jansen, H.J., Stienstra, R., van Diepen, J.A., Hijmans, A., van der Laak, J.A., Vervoort, G.M., et al. Start of insulin therapy in patients with type 2 diabetes mellitus promotes the influx of macrophages into subcutaneous adipose tissue. Diabetologia 56 (2013), 2573–2581.
34. TODAY Study Group. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med 366 (2012), 2247–2256.
35. Katz, L.L., Anderson, B.J., McKay, S.V., Izquierdo, R., Casey, T.L., Higgins, L.A., et al. Correlates of medication adherence in the TODAY cohort of youth with type 2 diabetes. Diabetes Care 39 (2016), 1956–1962 Epub 2016 Jun 28.